Comparison between Ace Alpha Tech IPO and Sheel Biotech IPO.
Ace Alpha Tech IPO is a SME Fixed Price IPO proposed to list at BSE SME while Sheel Biotech IPO is a SME Fixed Price proposed to list at NSE SME.
| Ace Alpha Tech IPO | Sheel Biotech IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Narnolia Financial Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | SS Corporate Securities Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Ace Alpha Tech IPO is up to ₹30.40 Cr whereas the issue size of the Sheel Biotech IPO is up to ₹0.00 Cr. The final issue price of Ace Alpha Tech IPO is ₹69.00 per share and of Sheel Biotech IPO is .
| Ace Alpha Tech IPO | Sheel Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | |
| Issue Price (Upper) | ₹69.00 per share | |
| Issue Price (Final) | ₹69.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | |
| Fresh Issue Size | 32,84,000 shares | 54,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹22.66 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 11,22,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹7.74 Cr | up to ₹0.00 Cr |
| Issue Size Total | 44,06,000 shares | 54,00,000 shares |
| Issue Size Total (Amount) | up to ₹30.40 Cr | up to ₹0.00 Cr |
Ace Alpha Tech IPO opens on Jun 26, 2025, while Sheel Biotech IPO opens on . The closing date of Ace Alpha Tech IPO and Sheel Biotech IPO is Jun 30, 2025, and , respectively.
| Ace Alpha Tech IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Jun 25, 2025 | |
| Issue Open | Jun 26, 2025 | |
| Issue Close | Jun 30, 2025 | |
| Basis Of Allotment (Tentative) | Jul 01, 2025 | |
| Initiation of Refunds (Tentative) | Jul 02, 2025 | |
| Credit of Share (Tentative) | Jul 02, 2025 | |
| Listing date (Tentative) | Jul 03, 2025 | |
| Anchor Lockin End date 1 | Jul 31, 2025 | |
| Anchor Lockin End date 2 | Sep 29, 2025 |
Ace Alpha Tech IPO P/E ratio is 9.07, as compared to Sheel Biotech IPO P/E ratio of .
| Ace Alpha Tech IPO | Sheel Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Ace Alpha Tech Limited Financial Information (Restated)
| Sheel Biotech Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 55.80 | 96.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 43.90 | 71.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹121.15 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 0.82 | 14.45% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 109.31% | 16.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.32 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.60 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 47.91% | 14.45% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Ace Alpha Tech IPO Retail Individual Investors (RII) are offered 15,44,000 shares while in Sheel Biotech IPO retail investors are offered 15,44,000 shares. Qualified Institutional Buyers (QIB) are offered 8,80,000 shares in Ace Alpha Tech IPO and in Sheel Biotech IPO.
| Ace Alpha Tech IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Investor Reserveration | 13,20,000 shares | |
| Market Maker Reserveration | 2,64,000 shares | 2,73,600 shares |
| QIB | 8,80,000 shares | |
| NII | 6,62,000 shares | |
| RII | 15,44,000 shares | |
| Employee | ||
| Others | ||
| Total | 44,06,000 shares |
Ace Alpha Tech IPO subscribed 101.75x in total, whereas Sheel Biotech IPO subscribed .
| Ace Alpha Tech IPO | Sheel Biotech IPO | |
|---|---|---|
| QIB (times) | 67.06x | |
| NII (times) | 170.79x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 91.92x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 101.75x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
